Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
bacteremia
biofilm
burn wound sepsis
conjunctivitis
cystic fibrosis
ecthyma gangrenosum
immunosuppressed
neutropenia
urinary tract infection
ventilator-associated pneumonia
Pseudomonas aeruginosa is a gram-negative rod and is a strict aerobe. It can multiply in a great variety of environments that contain minimal amounts of organic compounds. Strains from clinical specimens do not ferment lactose, are oxidase positive, and may produce β-hemolysis on blood agar. Many strains produce pigments, including pyocyanin, pyoverdine, and pyorubrin, that diffuse into and color the surrounding medium. Strains of P. aeruginosa are differentiated for epidemiologic purposes by a variety of genotyping methods, including restriction fragment length polymorphisms using pulsed-field gel electrophoresis, multilocus sequence typing, and more recently, whole genome sequencing.
P. aeruginosa is a classic “opportunist.” It rarely causes disease in people who do not have a predisposing risk factor. Compromised host defense mechanisms resulting from trauma, neutropenia, mucositis, immunosuppression, or impaired mucociliary transport explain the predominant role of this organism in producing opportunistic infections. In pediatric settings, it is most frequently seen in the respiratory secretions of children with cystic fibrosis (CF). P. aeruginosa was found in 1% of neonates with fever and bacteremia in a review of 6 U.S. centers. One series of neonatal intensive care unit (NICU) infections reported that 3.8%episodes of neonatal bacteremia from 1989–2003 were caused by P. aeruginosa . Another children's hospital reported 232 episodes of P. aeruginosa bacteremia over a 10 yr period, with half the infected children diagnosed with an underlying malignancy.
P. aeruginosa and other pseudomonads frequently enter the hospital environment on the clothes, skin, or shoes of patients or hospital personnel, with plants or vegetables brought into the hospital, and in the gastrointestinal (GI) tract of patients. Colonization of any moist or liquid substance may ensue; the organisms may be found growing in any water reservoir, including distilled water, and in hospital kitchen sinks and laundries, some antiseptic solutions, and equipment used for respiratory therapy and urinary procedures. Colonization of skin, throat, stool, and nasal mucosa of patients is low at admission to the hospital but increases to as high as 50–70% with prolonged hospitalization and with the use of broad-spectrum antibiotics, chemotherapy, mechanical ventilation, and urinary catheters. Patients’ intestinal microbial flora may be altered by the broad-spectrum antibiotics, reducing resistance to colonization and permitting P. aeruginosa in the environment to populate the GI tract. Intestinal mucosal breakdown associated with medications, especially cytotoxic agents, and nosocomial enteritis may provide a pathway by which P. aeruginosa spreads to the lymphatics or bloodstream.
The pathologic manifestations of P. aeruginosa infections depend on the site and type of infection. Because of its elaboration of toxins and invasive factors, the organism can often be seen invading blood vessels and causing vascular necrosis. In some infections there is spread through tissues with necrosis and microabscess formation. In patients with CF, focal and diffuse bronchitis/bronchiolitis leading to bronchiolitis obliterans has been reported.
Invasiveness of P. aeruginosa is mediated by a host of virulence factors. Bacterial attachment is facilitated by pili that adhere to epithelium damaged by prior injury or infection. Extracellular proteins, proteases, elastases, and cytotoxins disrupt cell membranes, and in response, host-produced cytokines cause capillary vascular permeability and induce an inflammatory response. Dissemination and bloodstream invasion follow extension of local tissue damage and are facilitated by the antiphagocytic properties of endotoxin, the exopolysaccharide, and protease cleavage of immunoglobulin G. P. aeruginosa also produces numerous exotoxins, including exotoxin A, which causes local necrosis and facilitates systemic bacterial invasion. P. aeruginosa possesses a type III secretion system composed of a needle structure that inserts into host cell membranes and allows secretion of exotoxins directly into host cells. P. aeruginosa strains with the gene encoding the type III secretion system–dependent phospholipase ExoU are associated with increased mortality compared with ExoU-negative strains, in retrospective studies of patients with P. aeruginosa ventilator-associated pneumonia . The host responds to infection with a robust inflammatory response, recruiting neutrophils to the infection site and producing antibodies to P. aeruginosa proteins such as exotoxin A and endotoxin. There is a lack of convincing data that these antibodies are protective against the establishment of infection.
In addition to acute infection, P. aeruginosa is also capable of chronic persistence thought to be partly a result of the formation of biofilms , organized communities of bacteria encased in an extracellular matrix that protects the organisms from the host immune response and the effects of antibiotics. Biofilm formation requires pilus-mediated attachment to a surface, proliferation of the organism, and production of exopolysaccharide as the main bacterial component of the extracellular matrix. A mature biofilm can persist despite an intense host immune response, is resistant to many antimicrobials, and is difficult to eradicate with current therapies.
Most clinical patterns are related to opportunistic infections in immunocompromised hosts (see Chapter 205 ) or are associated with shunts and indwelling catheters ( Chapter 206 ). P. aeruginosa may be introduced into a minor wound of a healthy person as a secondary invader, and cellulitis and a localized abscess that exudes green or blue pus may follow. The characteristic skin lesions of P. aeruginosa, ecthyma gangrenosum , whether caused by direct inoculation or a metastatic focus secondary to septicemia, begin as pink macules and progress to hemorrhagic nodules and eventually to ulcers with ecchymotic and gangrenous centers with eschar formation, surrounded by an intense red areola ( Table 232.1 and Fig. 232.1 ).
INFECTION | COMMON CLINICAL CHARACTERISTICS |
---|---|
Endocarditis | Native right-sided (tricuspid) valve disease with intravenous drug abuse |
Pneumonia | Compromised local (lung) or systemic host defense mechanisms; nosocomial (respiratory), bacteremic (malignancy), or abnormal mucociliary clearance (cystic fibrosis) may be pathogenetic; cystic fibrosis is associated with mucoid P. aeruginosa organisms producing capsular slime |
Central nervous system infection | Meningitis, brain abscess; contiguous spread (mastoiditis, dermal sinus tracts, sinusitis); bacteremia or direct inoculation (trauma, surgery) |
External otitis | Swimmer's ear; humid warm climates, swimming pool contamination |
Malignant otitis externa | Invasive, indolent, febrile toxic, destructive necrotizing lesion in young infants, immunosuppressed neutropenic patients, or diabetic patients; associated with 7th nerve palsy and mastoiditis |
Chronic mastoiditis | Ear drainage, swelling, erythema; perforated tympanic membrane |
Keratitis | Corneal ulceration; contact lens keratitis |
Endophthalmitis | Penetrating trauma, surgery, penetrating corneal ulceration; fulminant progression |
Osteomyelitis/septic arthritis | Puncture wounds of foot and osteochondritis; intravenous drug abuse; fibrocartilaginous joints, sternum, vertebrae, pelvis; open fracture osteomyelitis; indolent pyelonephritis and vertebral osteomyelitis |
Urinary tract infection | Iatrogenic, nosocomial; recurrent UTIs in children, instrumented patients, and those with obstruction or stones |
Intestinal tract infection | Immunocompromised, neutropenia, typhlitis, rectal abscess, ulceration, rarely diarrhea; peritonitis in peritoneal dialysis |
Ecthyma gangrenosum | Metastatic dissemination; hemorrhage, necrosis, erythema, eschar, discrete lesions with bacterial invasion of blood vessels; also subcutaneous nodules, cellulitis, pustules, deep abscesses |
Primary and secondary skin infections | Local infection; burns, trauma, decubitus ulcers, toe web infection, green nail (paronychia); whirlpool dermatitis; diffuse, pruritic folliculitis; vesiculopustular or maculopapular, erythematous lesions |
Outbreaks of dermatitis and urinary tract infections (UTIs) caused by P. aeruginosa have been reported in healthy persons after use of pools or hot tubs. Skin lesions of folliculitis develop several hours to 2 days after contact with these water sources. Skin lesions may be erythematous, macular, papular, or pustular. Illness may vary from a few scattered lesions to extensive truncal involvement. In some children, malaise, fever, vomiting, sore throat, conjunctivitis, rhinitis, and swollen breasts may be associated with dermal lesions. UTIs caused by P. aeruginosa are most often nosocomial and are often associated with the presence of an indwelling urinary catheter, urinary tract malformations, and previous antibiotic use. UTIs may be minimized or prevented by prompt removal of the catheter and by early identification and corrective surgery of obstructive lesions when present.
The surfaces of burns or wounds are frequently populated by P. aeruginosa and other gram-negative organisms; this initial colonization with a low number of adherent organisms is a prerequisite to invasive disease. P. aeruginosa colonization of a burn site may develop into burn wound sepsis , which has a high mortality rate when the density of organisms reaches a critical concentration. Administration of antibiotics may diminish the susceptible microbiologic flora, permitting strains of relatively resistant P. aeruginosa to flourish. Multiplication of organisms in devitalized tissues or associated with prolonged use of intravenous or urinary catheters increases the risk for septicemia with P. aeruginosa, a major problem in burned patients (see Chapter 92 ).
P. aeruginosa is common in children with CF, with a prevalence that increases with increasing age and severity of pulmonary disease (see Chapter 432 ). Initial infection is caused by nonmucoid environmental strains of P. aeruginosa, but after a variable period, mucoid strains of P. aeruginosa that produce the antiphagocytic exopolysaccharide alginate, which are rarely encountered in other conditions, predominate. Repeated isolation of mucoid P. aeruginosa from the sputum is associated with increased morbidity and mortality. The infection begins insidiously or even asymptomatically, and the progression has a highly variable pace. In children with CF, antibody does not eradicate the organism, and antibiotics are only partially effective; thus, after infection becomes chronic, it cannot be completely eradicated. Repeated courses of antibiotics select for P. aeruginosa strains that are resistant to multiple antibiotics.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here